Health Technology Assessment (HTA)

Similar documents
Health Technology Assessment (HTA)

Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30

The QLQ-C30 cut-off project - Symptom screening with the EORTC quality of life scales

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples

Background. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version

This is a repository copy of Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

PATIENTS REPORTED OUTCOMES IN ONCOLOGY PATIENT- CENTERED DRUG DEVELOPMENT: OPPORTUNITIES & CHALLENGES

EORTC QLQ-C30 descriptive analysis with the qlqc30 command

Quality of life in (haemato)oncology

Do patients consider computer-adaptive measures more appropriate than static questionnaires?

Quality of Life and Survivorship:

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

Københavns Universitet

Health Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017

Patient-reported outcome

Change in health-related quality of life over 1 month in cancer patients with high initial levels of symptoms and problems

Implementing Patient Report Outcome Data in Clinical Trials Analysis

Japan Journal of Medicine

Table of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix

Anota et al. Health and Quality of Life Outcomes 2014, 12:32

Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients

Quality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce

The Quality of Life of Chinese Middle-Aged Male Patients with Gastric Carcinoma After Total Gastrectomy and Nursing Intervention

QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For. Research Staff

ALK Inhibition: From Biology to Approved Therapy for Advanced Non-Small Cell Lung Cancer

Fanxing Hong 1*, Jaclyn L F Bosco 2, Nigel Bush 3 and Donna L Berry 2

How to Measure and Value Health Benefits to Facilitate Priority Setting for Pediatric Population? Development and Application Issues.

Patient Reported Outcomes

Original Article on Palliative Radiotherapy

10th anniversary of 1st validated CaPspecific

Chika Nwachukwu, Ph.D. MS IV Radiation Oncology Rotation

Quality Of Life Of The Patients With Ovarian Cancer

Prof Marion Eckert Rosemary Bryant AO Research Centre

THE UNIVERSITY OF SYDNEY CANCER RESEARCH NETWORK QUALITY OF LIFE SHOWCASE

Women s Health Development Unit, School of Medical Science, Health Campus, Universiti Sains Malaysia b

Author's response to reviews

LARYNGEAL CANCER IN EGYPT: QUALITY OF LIFE MEASUREMENT WITH DIFFERENT TREATMENT MODALITIES

Multidimensional fatigue and its correlates in hospitalized advanced cancer patients

A SAS Application for Analyzing Quality of Life data: NCIC-CTG Standard Method

VALUE IN HEALTH 19 (2016) Available online at journal homepage:

The Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life in Cancer

Symptom Benefit Committee. Chicago May 2018 F. Hilpert/JE Kurtz

Quality of Life assessment: A perspective from The EORTC

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D

ANZGOG Update. Symptom Working Group. Presentation prepared by Michael Friedlander

Supplementary Online Content

Major Challenges in Danish Cancer Care

Patient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life

Reliability and Validity of the Taiwan Chinese Version of the EORTC QLQ-PR25 in Assessing Quality of Life of Prostate Cancer Patients

Table 1: Controlled clinical trials of aromatherapy for cancer

Cross-cultural Psychometric Evaluation of the Dutch McGill- QoL Questionnaire for Breast Cancer Patients

Sanjeewa Kularatna 1,2*, Jennifer A. Whitty 1,2,3, Newell W. Johnson 2, Ruwan Jayasinghe 4 and Paul A. Scuffham 1,2

Symptom clusters using the EORTC QLQ-C15-PAL in palliative radiotherapy

Quality of life of patients after low anterior, intersphincteric, and abdominoperineal resection for rectal cancer a matched-pair analysis

COVERAGE WITH EVIDENCE DEVELOPMENT

PROMIS-29 V2.0 Physical and Mental Health Summary Scores. Ron D. Hays. Karen L. Spritzer, Ben Schalet, Dave Cella. September 27, 2017, 3:30-4:00pm

Validation Study of the Korean Version of the Brief Fatigue Inventory

INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures

Improving quality of life for people with dementia: the ADI-Stroud symposia

Sleep Insomnia Severity Index (SISI) Pittsburgh Sleep Quality Inventory. POMS Vigor subscale

A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches

Original Article. Abstract. Introduction. Das Priscilla 1, Awang Hamidin 2, Md Zain Azhar 2, Kon Noorjan 2, Md Said Salmiah 1, Khalid Bahariah 3

Ousmen et al. Health and Quality of Life Outcomes (2016) 14:167 DOI /s

Comparing Health Outcomes in Comparative Effectiveness Research: Do preferences matter? Benjamin M. Craig, Ph.D

3/5/2014. New Research Initiatives to Improve QoL of Persons with SCI Across the Globe. What Are the SCI International Datasets?

15D: Strengths, weaknesses and future development

Stated Preference Methods Research in Health Care Decision Making A Critical Review of Its Use in the European Regulatory Environment.

CHAPTER - III METHODOLOGY

ISSN: X (Print) X (Online) Journal homepage:

Electronic Capture of PROs in NCI Clinical Trials

Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study

ADDIS ABABA UNIVERSITY SCHOOL OF ALLIED HEALTH COLLEGE OF HEALTH SCIENCE DEPARTMENT OF NURSING AND MIDWIFERY

UvA-DARE (Digital Academic Repository)

Patient Reported Outcomes in an Era of Immunotherapy Drug Development. David Cella, PhD Northwestern University Chicago, IL, USA

The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System

European Wind Energy Association Oxford 12th December 2012

Supplementary Appendix

PROMIS Overview: Development of New Tools for Measuring Health-related Quality of Life and Related Outcomes in Patients with Chronic Diseases

CHAPTER 3 RESEARCH METHODOLOGY

In Woong Han 1, O Choel Kwon 1, Min Gu Oh 1, Yoo Shin Choi 2, and Seung Eun Lee 2. Departments of Surgery, Dongguk University College of Medicine 2

DEVELOPMENT THE VALIDATION OF INDONESIAN VERSION OF SF-36 QUESTIONNAIRE IN CANCER DISEASE. Dyah Ariani Perwitasari

Quality of Life in Patients with Chronic Myeloid Leukemia

Symptom Assessment Scale (SAS) + Palliative Care Problem Severity Score (PCPSS)

Be A Lab Rat - With Open2.net THE STROOP-TEST: CONFLICTING MESSAGES IN THE BRAIN

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

Health-Related Quality of Life in Brain Tumor Patients Treated with Surgery: Preliminary Result of a Single Institution

OVERALL CLINICAL BENEFIT

DISABILITY, PSYCHOLOGICAL DISTRESS AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS WITH ARM LYMPHEDEMA

Quality of life in patients with a permanent stoma after rectal cancer surgery

J Clin Oncol 25: by American Society of Clinical Oncology INTRODUCTION

LIHS Mini Master Class

Instruments Available for Use in Assessment Center

Running head: ARTICLE CRITIQUE 1

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin

Are touchscreen computer surveys acceptable to medical oncology patients?

Assessment of quality of life in patients with breast cancer receiving chemotherapy

A Gynecologic Cancer Intergroup Study of the NCIC Clinical Trials Group (NCIC CTG), the European Organization for Research and

Transcription:

Health Technology Assessment (HTA) Determination of utilities for the QLQ-C30 Georg Kemmler, Eva Gamper, Bernhard Holzner Department for Psychiatry and Psychotherapy Innsbruck Medical University Austria

Introduction Increasing importance of health economics and HTA in cancer research ( cost-utility analyses) Special utility based QOL instruments are required for performing such analyses (like EQ-5D, SF-6D) Development of utility-based versions of the QLQ-C30 has been intiated, but so far restricted to English language versions (AUS, UK) ( next page) Versions for various European countries with national utility weights are required to make the QLQ-C30 a competitive utility instrument

Utilities for the EORTC QLQ-C30 The larger framework Study 1 (D Rowen, J Brazier et al.*): Utilities for the QLQ-C30 in multiple myeloma patients based on 8 of the 30 EORTC QLQ-C30 items (EORTC-8D, finished) Study 2 (M King et al.**): Utilities for the QLQ-C30 in a general population sample Stage 1: Determination of the number of domains (finished, 10 domains/items ) Stage 2: Determination of utilites by Discrete Choice Experiments (feasibility testing just started) Study 2a (EORTC QLG, in cooperation with M. King et al.): Country-specific utilities for the QLQ-C30 (planning phase) * Rowen D, Brazier JE, Young TA, Gaugrist S, Craig BM, King MT, Velikova G. Value Health 2011 ** Consortium on Multi-Attribute Utility in Cancer MAUCa (M King,, N Aaronson, G Velikova et al.)

Determination of Utilities for the QLQ-C30 Graphical illustration EORTC QLQ- C30 PF EF SF RF CF GQOL Pain Fatigue Nausea Dyspnea Appetite loss Sleep disturbances Diarrhea Constipation Financial Impact Stage 1: Selection of key dimensions for generating health states (IRT - MAUCa) EORTC xd PF RF SF EF Pain Fatigue Nausea Constipation/Diarrh Appetite loss Sleep disturb. Stage 2: Determination of utilities by DCE EORTC utility score x1 * PF + x2 * RF + x3 * SF + x4 * EF + x5 * Pain + x6 * Fatigue + x7 * Nausea + x8*constipation/d + x9 * Appetite l. + x10* Sleep d. Depending on country (i.p. health care system), population (cancer vs healthy)

Steps Planned EORTC utility project* 1. Selection of EORTC QLQ-C30 dimensions/key items 2. Decision for utility elicitation method: TTO or DCE 3. Pilot study: Testing the feasibility of Discrete Choice Experiments (DCE) for utility elicitation 4. Main study: Elicitation of utilities for the EORTC QLQ-C30 (for several European countries) 5. Statistical analyses: estimation of EORTC utility weights, comparison between countries *In close cooperation with Madeleine King and the MAUCa team

Testing the feasibility of Discrete Choice Experiments (DCE) for utility elicitation: First results of the Austrian pilot study Small sample of healthy controls (N=47), patients planned Each participant had to complete 12 individual DCEs (comparisons Life A vs. Life B ) Two different designs tested: black and white vs color ( ) Test acceptability and feasibility Test for an effect of the design/layout

What does a Discrete Choice Experiment (DCE) look like? Example (simplified): Which of the two lives would you prefer? You will live in this situation for... years and then die Situation A Situation B 5 years 2 years Your physical condition or medical treatment interferes with your social or family life Very much A little You feel depressed Not at all A little Pain interferes with your daily activities Not at all Quite a bit You feel nauseated Very much Not at all Which situation would you prefer? In our case: Not 4 dimensions but 10! More complex task!

Version 1: black and white No colors for different categories

Version 2: color green (not at all) yellow (a little) - orange (quite a bit) - red (very much)

Results 1: Sample characteristics Variable Category Population Sample (N=47) Cancer Patients ongoing Age (Mean ± SD) 36 ± 15 (18 95) Gender Male 51% Female 49% Education Lower than A-levels 15% A-levels (Matura) 22.5% University 62.5% Health status No chron. disease or cancer 90% Cancer 0% chron. diseases 10%

Results 2: Acceptability & Feasibility Acceptability All persons approached were willing to participate No complaints about annoying or intrusive questions However: possible selection bias (fairly high level of education!) Feasibility Every respondent was able to understand the task Clear explanations were essential (set of dimensions, severity levels) Problems were mentioned by a considerable proportion of persons (e.g. difficulties to imagine certain health states/ combinations)

Results 3: First statistical analyses In 7 of the 12 individual DCEs: clear preference for one to the two situations (>80% for one option, <20% for the other) In 5 of the 12 DCEs: opinions were more split Most influential dimensions: Nausea and Fatigue Color vs. black & white: Majority preferred color (73%), so far no significant differences between color and b & w Limitations Utilities for individual health states can not yet be determined too few cases, too few distinct DCEs

Summary: Aims of the planned EORTC QLG project General aim: Determination of country-specific utilities for the EORTC QLQ-C30 - many countries - population sample and possibly cancer patients Phase I: Country-specific utilities for a few European countries (general population sample)

Many thanks for your attention!